Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells

Stem Cell Reviews and Reports

Volumn 6, Issue 4, 2010, Pages 548-559

  Kemp, Kevin ^a,b   Gray, Elizabeth ^a   Mallam, Elizabeth ^a   Scolding, Neil ^a   Wilkins, Alastair ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Central nervous system; Extracellular superoxide dismutase; Inflammation; Mesenchymal stem cell; Superoxide dismutase 3

Indexed keywords

CYTOKINE; GAMMA INTERFERON; NITRIC OXIDE; SOD3 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; METABOLISM; NERVE CELL; POLYMERASE CHAIN REACTION; RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DRUG SYNERGISM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MESENCHYMAL STEM CELLS; NEURONS; NITRIC OXIDE; POLYMERASE CHAIN REACTION; RATS; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957366312     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9178-6     Document Type: Article

References (56)

1. Halliwell, B. (2006). Oxidative stress and neurodegeneration: Where are we now? Journal of Neurochemistry, 97(6), 1634-1658.
2. Emerit, J., Edeas, M., & Bricaire, F. (2004). Neurodegenerative diseases and oxidative stress. Biomedicine & Pharmacotherapy, 58(1), 39-46.
3. Lin, M. T., & Beal, M. F. (2006). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443(7113), 787-795.
4. Rosen, D. R. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature, 364(6435), 362.
5. Parr, A. M., Tator, C. H., & Keating, A. (2007). Bone marrow-derived mesenchymal stromal cells for the repair of central nervous system injury. Bone Marrow Transplantation, 40(7), 609-619.
6. Wilkins, A., Kemp, K., Ginty, M., Hares, K., Mallam, E., & Scolding, N. (2009). Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res, 3(1), 63-70.
7. Arnhold, S., Klein, H., Klinz, F. J., et al. (2006). Human bone marrow stroma cells display certain neural characteristics and integrate in the subventricular compartment after injection into the liquor system. European Journal of Cell Biology, 85(6), 551-565.
8. Hokari, M., Kuroda, S., Shichinohe, H., Yano, S., Hida, K., & Iwasaki, Y. (2008). Bone marrow stromal cells protect and repair damaged neurons through multiple mechanisms. Journal of Neuroscience Research, 86(5), 1024-1035.
9. Crigler, L., Robey, R. C., Asawachaicharn, A., Gaupp, D., & Phinney, D. G. (2006). Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Experimental Neurology, 198(1), 54-64.
10. Lanza, C., Morando, S., Voci, A., et al. (2009). Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo. Journal of Neurochemistry, 110(5), 1674-1684.
11. Kemp, K., Hares, K., Mallam, E., Heesom, K. J., Scolding, N., & Wilkins, A. (2009). Mesenchymal stem cell-secreted superoxide dismutase promotes cerebellar neuronal survival. Journal of Neurochemistry, doi: 10. 1111/j. 1471-4159. 2009. 06553. x.
12. Ratnam, D. V., Ankola, D. D., Bhardwaj, V., Sahana, D. K., & Kumar, M. N. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Journal of Controlled Release, 113(3), 189-207.
13. Christofidou-Solomidou, M., & Muzykantov, V. R. (2006). Antioxidant strategies in respiratory medicine. Treatments in Respiratory Medicine, 5(1), 47-78.
14. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147.
15. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317.
16. Kim, Y. J., Park, H. J., Lee, G., et al. (2009). Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action. Glia, 57(1), 13-23.
17. Broholm, H., Andersen, B., Wanscher, B., et al. (2004). Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurologica Scandinavica, 109(4), 261-269.
18. Smith, K. J., Kapoor, R., & Felts, P. A. (1999). Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathology, 9(1), 69-92.
19. Mohamed, A., Shoker, A., Bendjelloul, F., et al. (2003). Improvement of experimental allergic encephalomyelitis (EAE) by thymoquinone; an oxidative stress inhibitor. Biomedical Sciences Instrumentation, 39, 440-445.
20. Ruuls, S. R., van Der Linden, S., Sontrop, K., Huitinga, I., & Dijkstra, C. D. (1996). Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clinical and Experimental Immunology, 103(3), 467-474.
21. Qi, X., Sun, L., Lewin, A. S., Hauswirth, W. W., & Guy, J. (2007). Long-term suppression of neurodegeneration in chronic experimental optic neuritis: Antioxidant gene therapy. Investig Ophthalmol Vis Sci, 48(12), 5360-5370.
22. Nozik-Grayck, E., Suliman, H. B., & Piantadosi, C. A. (2005). Extracellular superoxide dismutase. The International Journal of Biochemistry & Cell Biology, 37(12), 2466-2471.
23. Brown, G. C., & Borutaite, V. (2006). Interactions between nitric oxide, oxygen, reactive oxygen species and reactive nitrogen species. Biochemical Society Transactions, 34(Pt 5), 953-956.
24. Lob, H. E., Marvar, P. J., Guzik, T. J., et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension, 55(2), 277-283.
25. Laurila, J. P., Laatikainen, L. E., Castellone, M. D., & Laukkanen, M. O. (2009). SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression. PLoS ONE, 4(6), e5786.
26. Folz, R. J., Abushamaa, A. M., & Suliman, H. B. (1999). Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. Journal of Clinical Investigation, 103(7), 1055-1066.
27. Bowler, R. P., Nicks, M., Tran, K., et al. (2004). Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation. American Journal of Respiratory Cell and Molecular Biology, 31(4), 432-439.
28. Gao, F., Koenitzer, J. R., Tobolewski, J. M., et al. (2008). Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. The Journal of Biological Chemistry, 283(10), 6058-6066.
29. Ha, H. Y., Kim, Y., Ryoo, Z. Y., & Kim, T. Y. (2006). Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD. Biochemical and Biophysical Research Communications, 348(2), 450-458.
30. Lubrano, V., Di Cecco, P., & Zucchelli, G. C. (2006). Role of superoxide dismutase in vascular inflammation and in coronary artery disease. Clinical and Experimental Medicine, 6(2), 84-88.
31. Rabbani, Z. N., Anscher, M. S., Folz, R. J., et al. (2005). Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity. BMC Cancer, 5(59).
32. Ueda, J., Starr, M. E., Takahashi, H., et al. (2008). Decreased pulmonary extracellular superoxide dismutase during systemic inflammation. Free Radical Biology & Medicine, 45(6), 897-904.
33. Marklund, S. L. (1990). Expression of extracellular superoxide dismutase by human cell lines. The Biochemical Journal, 266(1), 213-219.
34. Harris, C. A., Derbin, K. S., Hunte-McDonough, B., et al. (1991). Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumor necrosis factor or IL-1. Journal of Immunology, 147(1), 149-154.
35. Marklund, S. L. (1992). Regulation by cytokines of extracellular superoxide dismutase and other superoxide dismutase isoenzymes in fibroblasts. The Journal of Biological Chemistry, 267(10), 6696-6701.
36. Olofsson, E. M., Marklund, S. L., Pedrosa-Domellof, F., & Behndig, A. (2007). Interleukin-1alpha downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells. Molecular Vision, 13, 1285-1290.
37. Stralin, P., & Marklund, S. L. (2000). Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis, 151(2), 433-441.
38. Stralin, P., & Marklund, S. L. (2001). Vasoactive factors and growth factors alter vascular smooth muscle cell EC-SOD expression. American Journal of Physiology. Heart and Circulatory Physiology, 281(4), H1621-H1629.
39. Nathan, C. F., Murray, H. W., Wiebe, M. E., & Rubin, B. Y. (1983). Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. The Journal of Experimental Medicine, 158(3), 670-689.
40. Berkow, R. L., Wang, D., Larrick, J. W., Dodson, R. W., & Howard, T. H. (1987). Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. Journal of Immunology, 139(11), 3783-3791.
41. Matsubara, T., & Ziff, M. (1986). Increased superoxide anion release from human endothelial cells in response to cytokines. Journal of Immunology, 137(10), 3295-3298.
42. Tiku, M. L., Liesch, J. B., & Robertson, F. M. (1990). Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. Journal of Immunology, 145(2), 690-696.
43. Benveniste, E. N., & Benos, D. J. (1995). TNF-alpha- and IFN-gamma-mediated signal transduction pathways: Effects on glial cell gene expression and function. The FASEB Journal, 9(15), 1577-1584.
44. Shi, N., Kawano, Y., Matsuoka, T., et al. (2009). Increase of CD4 + TNF{alpha} + IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients. Multiple Sclerosis, 15(1), 120-123.
45. Baraczka, K., Pozsonyi, T., Szuts, I., Ormos, G., & Nekam, K. (2003). Increased levels of tumor necrosis alpha and soluble vascular endothelial adhesion molecule-1 in the cerebrospinal fluid of patients with connective tissue diseases and multiple sclerosis. Acta Microbiologica et Immunologica Hungarica, 50(4), 339-348.
46. Sharief, M. K., Noori, M. A., Ciardi, M., Cirelli, A., & Thompson, E. J. (1993). Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. Journal of Neuroimmunology, 43(1-2), 15-21.
47. Jensen, M. B., Hegelund, I. V., Lomholt, N. D., Finsen, B., & Owens, T. (2000). IFNgamma enhances microglial reactions to hippocampal axonal degeneration. The Journal of Neuroscience, 20(10), 3612-3621.
48. Renno, T., Taupin, V., Bourbonniere, L., et al. (1998). Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Molecular and Cellular Neurosciences, 12(6), 376-389.
49. Renno, T., Krakowski, M., Piccirillo, C., Lin, J. Y., & Owens, T. (1995). TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. Journal of Immunology, 154(2), 944-953.
50. Stralin, P., & Marklund, S. L. (1994). Effects of oxidative stress on expression of extracellular superoxide dismutase, CuZn-superoxide dismutase and Mn-superoxide dismutase in human dermal fibroblasts. Biochemical Journal, 298(Pt 2), 347-352.
51. Abrams, M. B., Dominguez, C., Pernold, K., et al. (2009). Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury. Restorative Neurology and Neuroscience, 27(4), 307-321.
52. Park, H. J., Lee, P. H., Ahn, Y. W., et al. (2007). Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. The European Journal of Neuroscience, 26(1), 79-89.
53. Vercelli, A., Mereuta, O. M., Garbossa, D., et al. (2008). Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiology of Disease, 31(3), 395-405.
54. Chopp, M., & Li, Y. (2002). Treatment of neural injury with marrow stromal cells. Lancet Neurology, 1(2), 92-100.
55. Mahmood, A., Lu, D., Lu, M., & Chopp, M. (2003). Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery, 53(3), 697-702. discussion 702-3.
56. Mahmood, A., Lu, D., Qu, C., Goussev, A., & Chopp, M. (2005). Human marrow stromal cell treatment provides long-lasting benefit after traumatic brain injury in rats. Neurosurgery, 57(5), 1026-1031. discussion 1026-31.